A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
DF Vestrheim, IS Aaberge, BS Wiklund… - Epidemiology & …, 2014 - cambridge.org
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
[PDF][PDF] A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A STEENS, DF VESTRHEIM, IS AABERGE… - Epidemiol …, 2014 - cambridge.org
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged 52 years to prevent invasive pneumococcal disease …
has been available for risk groups aged 52 years to prevent invasive pneumococcal disease …
[PDF][PDF] A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A Steens, IS Aaberge, J Storsaeter… - Epidemiol. Infect, 2014 - academia.edu
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged 52 years to prevent invasive pneumococcal disease …
has been available for risk groups aged 52 years to prevent invasive pneumococcal disease …
A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.
A Steens, DF Vestrheim, IS Aaberge… - Epidemiology and …, 2014 - europepmc.org
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged [gt-or-equal, slanted] 2 years to prevent invasive …
has been available for risk groups aged [gt-or-equal, slanted] 2 years to prevent invasive …
A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.
A STEENS, DF VESTRHEIM… - Epidemiology & …, 2014 - search.ebscohost.com
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A STEENS, DF VESTRHEIM… - Epidemiology and …, 2014 - search.proquest.com
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged [= or>, slanted] 2 years to prevent invasive …
has been available for risk groups aged [= or>, slanted] 2 years to prevent invasive …
[HTML][HTML] A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A STEENS, DF VESTRHEIM, IS AABERGE… - Epidemiology and …, 2014 - ncbi.nlm.nih.gov
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A Steens, DF Vestrheim, IS Aaberge… - Epidemiology and …, 2014 - pubmed.ncbi.nlm.nih.gov
For decades, vaccination with the 23-valent polysaccharide pneumococcal vaccine (PPV23)
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
has been available for risk groups aged⩾ 2 years to prevent invasive pneumococcal …
[引用][C] A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older
A STEENS, DF VESTRHEIM… - Epidemiology and …, 2014 - pascal-francis.inist.fr
A review of the evidence to inform pneumococcal vaccine recommendations for risk groups
aged 2 years and older CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
aged 2 years and older CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Paper VI
A Steens, DF Vestrheim… - A SCIENTIFIC BASIS …, 2019 - researchgate.net
abstract Two different vaccines, a 23-valent polysaccharide vaccine (PPV23) and a 13-
valent conjugate vaccine (PCV13), are available for prevention of invasive pneumococcal …
valent conjugate vaccine (PCV13), are available for prevention of invasive pneumococcal …